Cancer immunotherapy-targeted glypican-3 or neoantigens-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer immunotherapy-targeted glypican-3 or neoantigens

Published:2018-02-14 Issue:3 Volume:109 Page:531-541
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Shimizu Yasuhiro¹²^ORCID,Suzuki Toshihiro¹,Yoshikawa Toshiaki¹,Tsuchiya Nobuhiro¹²,Sawada Yu¹²,Endo Itaru²,Nakatsura Tetsuya¹

Affiliation:

1. Division of Cancer Immunotherapy; Exploratory Oncology Research and Clinical Trial Center; National Cancer Center; Kashiwa Japan

2. Department of Gastroenterological Surgery; Graduate School of Medicine; Yokohama City University; Yokohama Japan

Funder

National Cancer Center

Health and Labor Science Research Grants for Clinical Research, Japan

Takeda Pharmaceutical Company

Noile-Immune Biotech Inc.

Ono Pharmaceutical Co., Ltd.

BrightPath Biotherapeutics Co., Ltd.

Sysmex Co., Ltd.

National Cancer Center Research and Development Fund

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.13485/fullpdf

Reference61 articles.

1. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N Engl J Med,2014

2. Adoptive immunotherapy for cancer: building on success;Gattinoni;Nat Rev Immunol,2006

3. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma;Hamid;N Engl J Med,2013

4. CTLA-4and PD-1 pathway blockade: combinations in the clinic;Callahan;Front Oncol,2015

5. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy;Apetoh;Nat Med,2007

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiomic Analysis of Contrast-Enhanced CT Predicts Glypican 3-Positive Hepatocellular Carcinoma;Current Medical Imaging Reviews;2024-04-25

2. Unlocking the Potential of Induced Pluripotent Stem Cells in Revolutionizing Cancer Therapy;Current Stem Cell Research & Therapy;2024-04-15

3. Administration of a glypican‐3 peptide increases the infiltration and cytotoxicity of CD8⁺ T cells against testicular yolk sac tumor, associated with enhancing the intratumoral cGAS/STING signaling;Cancer Medicine;2023-11-20

4. Innate immune response restarts adaptive immune response in tumors;Frontiers in Immunology;2023-09-14

5. Glypican-3 knockdown inhibits the cell growth, stemness, and glycolysis development of hepatocellular carcinoma cells under hypoxic microenvironment through lactylation;Archives of Physiology and Biochemistry;2023-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3